Dermatology Products · LP-095
Permethrin Cream
Generic medicine development record. Review the proposed presentation and the professional reference information below.
Development record
- Portfolio reference
- LP-095Dermatology Products
- Generic identity
- PermethrinCream
- Registration
- Not establishedProduct-specific evidence required
- Availability
- Not marketedNo offer of supply
01 · Ingredient reference
Record identity and reference background.
- Portfolio reference
- LP-095
- Generic ingredient
- Permethrin
- Dosage form
- Cream
- Proposed strength
- 5%
- Proposed pack
- Tube 30 g / 60 g
- Portfolio category
- Dermatology Products
About Permethrin
Permethrin is an antiparasitic ingredient used in topical medicines. The cream presentation in this catalogue concerns a different formulation from common head-lice lotions. Its medical role depends on the parasite, concentration, age group and locally authorized label. Scabies management also involves recognising close-contact transmission and coordinating care, rather than treating a skin symptom in isolation. The information here is an educational description of the ingredient and formulation.
How to read this profile
Scientific information relates to the ingredient and dosage-form context. It is not approved Luang Pharma labelling, a clinical recommendation, or evidence of equivalence to a referenced product. Multiple strengths or presentations represent separate proposed variants and must not be treated as interchangeable.
02 · Professional background
Scientific & clinical reference
Read the clinical context, selected safety considerations and presentation-specific information below.
Clinical context and therapeutic role
Clinicians distinguish scabies from other itchy skin disorders and assess whether close contacts need coordinated evaluation. Itching can continue after successful treatment, so continued itch does not automatically prove resistance or justify repeated application. Crusted scabies, outbreaks and infection in vulnerable people need specific professional management. General references may cover both lice and scabies products; their application instructions cannot be transferred between the two formulations or used as a Luang Pharma label.
Important safety considerations
Burning, stinging, redness and increased itching may occur. Trouble breathing or marked irritation requires prompt medical attention. Avoid contact with eyes and mucosal surfaces, and prevent accidental ingestion. Young children, pregnancy, inflamed or broken skin and previous reactions to permethrin require product-specific assessment. Unnecessary repeat applications may worsen irritation; suspected treatment failure should trigger review of diagnosis, correct use and contact management.
These are selected considerations, not a complete list. Use the current instructions or approved label for the exact authorised product and seek appropriate professional advice.
Presentation, handling and storage
This entry describes cream rather than a shampoo, lotion or environmental insecticide. Concentrations used in other permethrin products are not interchangeable. Verify the approved route, coverage instructions and supplied leaflet before considering any presentation for use.
Keep the medicine in the labelled original pack with its leaflet. Check the expiry date and pack integrity before dispensing. The authorized label must determine storage temperature, protection from moisture or light, and disposal; no shelf life or in-use period can be established from a catalogue entry.
Final composition, instructions, shelf life and storage conditions are not established by this portfolio entry. They must come from the controlled documentation for the specific product.
Points for professional review
Confirm the parasitic diagnosis and formulation. Review patient age, exposure history, household or institutional contacts and the follow-up plan under applicable clinical guidance.
03 · Product enquiry
Documentation & regulatory status
Evidence status
What is established — and what remains open
This record has received an editorial evidence-layer review. The review separates catalogue facts from unresolved product-specific fields and external context; it is not medical, regulatory or market-authorisation approval.
Layer 01
Controlled catalogue facts
- Generic ingredient
- Permethrin
- Dosage form / presentation
- Cream
- Catalogue strength
- 5%
- Catalogue pack
- Tube 30 g / 60 g
- Portfolio category
- Dermatology Products
Layer 02
Unresolved product-specific fields
- Exact vehicle/excipient system, intended application site and formulation-specific instructions require controlled product documentation.
- Approved indication, patient eligibility and dosing are not established by this portfolio record.
- Registration, manufacturing/site status, supply availability, storage conditions and shelf life remain product- and market-specific evidence items.
Layer 03
Attributed external context
- MedlinePlus: Permethrin — ingredient/formulation referencegovernment-hosted medicine monograph
- CDC: clinical care of scabiesgovernment or public health guidance
These references provide scientific or regulatory context only. They are not Luang Pharma product labelling, registration, manufacturing evidence, equivalence evidence or confirmation of supply.
Layer 04
Documents required to close the record
- Controlled product master/specification confirming the exact ingredient identity, dosage form, strength variant and pack mapping.
- Destination-market authorisation or other lawful supply-route evidence plus the approved label/leaflet/IFU, where applicable.
- Product-specific composition/excipient, storage, shelf-life and pack-control documentation.
- Manufacturing-site and supply-status evidence before any public claim of installed capability, registration, availability or equivalence.
For LP-095, identify the destination country, intended professional use, proposed presentation and the role of your organisation. The appropriate supply route and available documentation must be confirmed for that case.
- Confirm the legal entity, manufacturing site and authorised scope for the proposed supply chain.
- Confirm product registration or another lawful route, approved labelling and the applicable destination requirements.
- Request relevant product information, specifications and supporting evidence through the company contact.
- Confirm storage, transport, traceability, complaints and safety-reporting responsibilities before any agreement.
The public catalogue extends beyond the initial planned facility modules. A listing does not mean that the dosage form is installed, qualified or licensed at Boten.
04 · External sources
Sources and further reading
External sources are provided for reference. Their authors do not endorse Luang Pharma, and another product’s authorisation does not transfer to this portfolio record. Source availability and wording can change.
Professional enquiries
Request product-specific evidence for LP-095.
State the exact presentation, organisation, destination and evidence needed. This public record is not an offer of supply.